INTERNATIONAL PATENT: SENJU PHARMACEUTICAL CO., LTD., 千寿製薬株式会社, MOCHIDA PHARMACEUTICAL CO., LTD., 持田製薬株式会社 FILES APPLICATION FOR "HETEROCYCLIDENE-ACETAMIDE-DERIVATIVE-CONTAINING COMPOSITION SUBJECTED TO ELECTRON BEAM STERILIZATION TREATMENT"

Posted On: 2025-10-05

GENEVA, Oct. 5 -- SENJU PHARMACEUTICAL CO., LTD. (3-1-9, Kawara-machi, Chuo-ku, Osaka-shi, Osaka5410048), 千寿製薬株式会社 (大阪府大阪市中央区瓦町三丁目１番９号), MOCHIDA PHARMACEUTICAL CO., LTD. (7, Yotsuya 1-chome, Shinjuku-ku, Tokyo1608515), 持田製薬株式会社 (東京都新宿区四谷一丁目７番地) filed a patent application (PCT/JP2025/012451) for "HETEROCYCLIDENE-ACETAMIDE-DERIVATIVE-CONTAINING COMPOSITION SUBJECTED TO ELECTRON BEAM STERILIZATION TREATMENT" on Ma...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SENJU PHARMACEUTICAL CO., LTD., 千寿製薬株式会社, MOCHIDA PHARMACEUTICAL CO., LTD., 持田製薬株式会社 FILES APPLICATION FOR "HETEROCYCLIDENE-ACETAMIDE-DERIVATIVE-CONTAINING COMPOSITION SUBJECTED TO ELECTRON BEAM STERILIZATION TREATMENT"